--- title: "AstraZeneca (AZN) Receives a Buy from Berenberg Bank" type: "News" locale: "en" url: "https://longbridge.com/en/news/298611271.md" description: "Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Hector is a 4-star analyst with an average return of 4.7% and a 57.25% success rate. Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Merck & Company. In addition to Berenberg Bank, AstraZeneca also received a Buy from Goldman Sachs’s Rajan Sharma in a report issued yesterday. However, on September 8, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN)." datetime: "2026-09-10T14:05:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298611271.md) - [en](https://longbridge.com/en/news/298611271.md) - [zh-HK](https://longbridge.com/zh-HK/news/298611271.md) generator: "portal-rs" --- # AstraZeneca (AZN) Receives a Buy from Berenberg Bank Berenberg Bank analyst Luisa Hector maintained a Buy rating on AstraZeneca today and set a price target of £160.00. According to TipRanks, Hector is a 4-star analyst with an average return of 4.7% and a 57.25% success rate. Hector covers the Healthcare sector, focusing on stocks such as AstraZeneca, Sanofi, and Merck & Company. In addition to Berenberg Bank, AstraZeneca also received a Buy from Goldman Sachs’s Rajan Sharma in a report issued yesterday. However, on September 8, Deutsche Bank maintained a Sell rating on AstraZeneca (LSE: AZN). ### Related Stocks - [AZN.US](https://longbridge.com/en/quote/AZN.US.md) - [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md) - [SNY.US](https://longbridge.com/en/quote/SNY.US.md) - [MRK.US](https://longbridge.com/en/quote/MRK.US.md) - [GS.US](https://longbridge.com/en/quote/GS.US.md) - [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md) - [DB.US](https://longbridge.com/en/quote/DB.US.md) - [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md) - [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md) - [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md) - [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md) ## Related News & Research - [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md) - [Key facts: AstraZeneca (AZN) NICE OK Enhertu; FDA review; China plan](https://longbridge.com/en/news/299411391.md) - [AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears](https://longbridge.com/en/news/298828016.md) - [Cellectis pivots to in vivo gene editing, restructures operations to extend cash runway into H2 2028](https://longbridge.com/en/news/298875964.md) - [Key facts: LSE:AZN Zegfrovy buy; SANOVO PFS; Wan Ling Martello named](https://longbridge.com/en/news/297611733.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**